Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 -13.17M
March 31, 2026 -12.29M
December 31, 2025 -11.91M
September 30, 2025 -11.24M
June 30, 2025 -9.083M
Date Value
March 31, 2025 -8.272M
December 31, 2024 -8.065M
September 30, 2024 -8.332M
June 30, 2024 -7.879M
March 31, 2024 -6.683M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Abbott Laboratories 7.824B
AngioDynamics, Inc. -3.873M
Alphatec Holdings, Inc. -5.739M
AtriCure, Inc. 53.11M
Baxter International, Inc. 812.00M